Ispire Technology (ISPR) investor relations material

Executive summary

• Revenue for Q1 FY2026 was $30.4 million, down 22.8% year-over-year, reflecting a strategic shift to higher-quality customers and reduced exposure to the cannabis industry.

• Net loss improved to $3.3 million ($0.06 per share) from $5.6 million ($0.10 per share) in the prior year, with significant reductions in operating expenses due to cost controls and disciplined expense management.

• Gross margin declined to 17.0% from 19.5% year-over-year, primarily due to product mix changes and less higher-margin product sales.

• Non-GAAP EBITDA reached $0.6 million for the quarter, reflecting operational improvements.

• The company continues to expand internationally, invest in manufacturing and joint ventures, and pursue technological innovation, especially in age-gating and GMASH technologies.

Financial highlights

• Revenue: $30.4 million (down 22.8% year-over-year); gross profit: $5.1 million (down 32.9% year-over-year); gross margin: 17.0%.

• Operating expenses dropped 39% to $7.8 million from $12.9 million year-over-year.

• Net loss: $3.3 million, improved from $5.6 million loss in prior year.

• Cash and cash equivalents stood at $22.7 million as of September 30, 2025.

• Working capital was $9.3 million at quarter end.

Outlook and guidance

• Management expects continued cost reduction, improved profitability, and strengthened cash flow throughout fiscal 2026.

• Anticipation of further revenue growth from ODM partnerships, new licensing agreements, and ramping up production at the Malaysian manufacturing facility.

• Management expects current cash, operating cash flows, and recent equity offerings to be sufficient for the next 12 months, but additional financing may be required if adverse conditions arise or accelerated growth is pursued.